S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

CTXR Citius Pharmaceuticals Inc

2.67

0.02 (0.75%)

Feb 07 2025 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Citius Pharmaceuticals Charts.

Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Citius Pharmaceuticals Charts.

Citius Pharmaceuticals Inc News

Form 8-K - Current report
Thursday 6 February 2025 (3 days ago) • Edgar (US Regulatory)

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services
Thursday 6 February 2025 (3 days ago) • PR Newswire (US)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Monday 27 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Monday 27 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 27 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 27 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Thursday 16 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Wednesday 8 January 2025 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 7 January 2025 (1 month ago) • Edgar (US Regulatory)

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025
Tuesday 7 January 2025 (1 month ago) • PR Newswire (US)

More Citius Pharmaceuticals Inc News Articles

Bmo Concentrated Global ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions